Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Research & Development (2022 - 2025)

Envoy Medical's Research & Development history spans 4 years, with the latest figure at $4.6 million for Q4 2025.

  • Quarterly results put Research & Development at $4.6 million for Q4 2025, up 84.26% from a year ago — trailing twelve months through Dec 2025 was $12.5 million (up 22.66% YoY), and the annual figure for FY2025 was $12.5 million, up 22.66%.
  • Research & Development for Q4 2025 was $4.6 million at Envoy Medical, up from $2.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $4.6 million in Q4 2025 to a low of $935000.0 in Q3 2022.
  • The 4-year median for Research & Development is $2.5 million (2024), against an average of $2.4 million.
  • The sharpest move saw Research & Development surged 111.71% in 2023, then decreased 19.12% in 2024.
  • Year by year, Research & Development stood at $1.4 million in 2022, then skyrocketed by 111.71% to $3.1 million in 2023, then decreased by 19.12% to $2.5 million in 2024, then skyrocketed by 84.26% to $4.6 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $4.6 million, $2.7 million, and $2.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.